Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosis.
Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.
[Animal models for multiple sclerosis].
Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients.
A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir Valley of India.
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach.
[Argyrophil fibrils in the foci of multiple sclerosis; tissue in the central nervous parenchyma].
Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
Alemtuzumab for the treatment of multiple sclerosis.
Is it correct for a woman with multiple sclerosis to forgo medication because she may become pregnant?
[Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.]
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
Ultrasonography of MADSAM neuropathy: Focal nerve enlargements at sites of existing and resolved conduction blocks.
EAE: imperfect but useful models of multiple sclerosis.
Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.
Dimethylfumarate Impairs Neutrophil Functions.
Prednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis.
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor.
Neuromyelitis optica spectrum disorders in Algeria: A preliminary study in the region of Tizi Ouzou.
Reliability and validity of the function in sitting test in nonambulatory individuals with multiple sclerosis.
[EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN ADULT RATS AFTER ADMINISTRATION OF INTERLEUKIN-1beta DURING DIFFERENT PERIODS OF EARLY LIFE].
CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
Pages
« first
‹ previous
…
704
705
706
707
708
709
710
711
712
…
next ›
last »